By adopting a multivendor approach to outsourcing, sponsors are increasing their management of combinations of focused and niche CRO service providers in order to address specific project requirements. The year 2000 will be remembered as a period of highly active market response to the opportunities inherent in a rapidly changing environment. Most of this response came from small, independent players and the academic community. As many SMOs faced slower than expected growth, AMCs and dedicated sites had their best years ever. E-technology solutions providers aggressively targeted the industry.
Government agencies provide a wealth of information about published reports and new regulations.
Other sites are listing contract service and company profiles, job listings and industry news. And pharmaceutical companies have begun to be more forthcoming with pipeline information. CenterWatch has identified a clinical research pipeline of approximately 23 drugs. These include drugs that have been previously approved for the treatment of Parkinson's disease and newly developed compounds.